InvestorsHub Logo
Followers 698
Posts 59465
Boards Moderated 18
Alias Born 06/01/2008

Re: wasdeafonce post# 167

Saturday, 06/09/2018 12:10:52 AM

Saturday, June 09, 2018 12:10:52 AM

Post# of 245
"I understand. I read somewhere it takes a month or two.

Thanks again!"

JohnCM

From: Stephanie Van Hassel [mailto:stephanie@medmen.com]
Sent: Friday, June 8, 2018 11:07 PM
To: JohnCM
Subject: Re: MedMen Will Commence Trading May 29th Under Ticker Symbol "MMEN"

Hi John,

The new ticker is not DTC eligible at this moment in time.

Kind regards,
Stéphanie
Sent from my iPhone

On Jun 8, 2018, at 20:52, John wrote:
I have your new sponsored OTC ticker. Do you happen to know if it is DTC eligible yet?

Thank you ... Good move! Reacting and staying flexible. Good sign.

MedMen Revises Executive Compensation Plans

June 08, 2018 05:02 PM Eastern Daylight Time

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (CSE: MMEN) (“MedMen”), the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, announced today that the grant units for its co-founders under its long-term incentive plan (the “LTIP”) will now vest upon achievement of certain share price goals.

Co-founder and CEO Adam Bierman and Co-founder and President Andrew Modlin will receive their LTIP units of MM Enterprises USA LLC according to the following schedule. One third of the total units will vest when the price of MedMen’s Subordinated Voting Shares reaches CA$ 10 in the open market, another third will vest when the share price reaches CA$ 15 and the final third when the share price reaches CA$ 20. The price will be determined as a 5-day VWAP in any exchange where MedMen shares are traded.

This modification to the grants under the LTIP was made to provide greater economic alignment with MedMen’s shareholders.

About MedMen

MedMen Enterprises is the preeminent cannabis company in the United States with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America’s addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is one of the most well recognized cannabis brands in the world today. Headquartered in Los Angeles, MedMen employs 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws. The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates. For more information, visit http://www.medmen.com or follow us on Facebook, Twitter or Instagram.

Source: MedMen Enterprises

Contacts
Media Contact:
Daniel Yi
Senior Vice President of Corporate Communications, MedMen Enterprises
daniel@medmen.com
or
Investor Relations Contact:

"Hello MEDMEN,

I was super excited about Medmen trading publicly in CA and eventually with a U.S. foreign issue OTC ticker. I opened a couple discussion boards on Investors HUB and was truly excited about investing in stock in this company.

I live in the U.S.

And then came the press about the use of the public company initial proceeds and the percentage of the company that individual investors would hold when investing in company shares.

The numbers here are rough and approximate.

Of the $100,000,000 in proceeds, approx half of that went directly into the pockets of the principals.

Roughly 7 percent of the company is owned by investors of company stock.

These numbers are ghastly and I declined to invest in Medmen.

How is the company going to repair its tarnished image with the investment community?"

JohnCM




From: Stéphanie Van Hassel [mailto:stephanie@medmen.com]
Sent: Tuesday, June 5, 2018 1:19 PM
To: John
Subject: Re: MedMen Will Commence Trading May 29th Under Ticker Symbol "MMEN"

MTTPF is not a MedMen sponsored ticker. We will issue a press release with further details if/when MedMen enters the OTC market. If you have not done so already, please sign up for investor alerts on our website.

Kind regards,
Stéphanie

On Tue, Jun 5, 2018 at 11:12 AM, John wrote:
MTTPF

no announcement or mention on website?

Volume, but on the grey sheet.

Perhaps you are waiting for uplist to at least pink?

John

From: Stéphanie Van Hassel [mailto:stephanie@medmen.com]
Sent: Sunday, May 27, 2018 3:55 PM
To: undisclosed-recipients:
Subject: MedMen Will Commence Trading May 29th Under Ticker Symbol “MMEN”

We are thrilled to announce that we are on track to commence trading this coming Tuesday, May 29th on the Canadian Securities Exchange (CSE) under the ticker symbol, MMEN. Additionally, we closed our concurrent financing round on Friday, May 25th, raising CAD 143.0 million at CAD 5.25 per share with a valuation of CAD 2.14 billion.

We thank you for your continued support and interest in MedMen.

Kind regards,
Stéphanie

--
Stéphanie Van Hassel
Head of Investor Relations
C: (917) 650-8671
www.MedMen.com